StockpollyBeta
Get App
Popularity #3,423
GOSS · NASDAQ · Biotechnology

Gossamer Bio (GOSS)

Develops inhaled seralutinib for pulmonary arterial hypertension and PH-ILD.

$11.71
After hours−0.09 (−0.76%)
At close$11.80(+4.61%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000969910111314179
Cost of revenue000000000000
Gross profit000969910111314179
404942444346475062606235
Research & development313032353536384253494326
991099999911199
General & administrative991099999911199
Other expenses0100000000000
Operating income−40−49−4252−34−36−37−39−49−46−45−26
010221001−1−243
Interest income00020−1011000
Interest expense333333333333
Other non-operating income−4−4−3−4−5−3−3−3−4−1−145
Income before tax−40−48−4254−32−35−37−38−48−47−4717
Income tax expense0004−1−2000000
Net income from continuing operations−40−48−4249−31−33−37−38−48−47−4717
Net income−40−48−4249−31−33−37−38−48−47−4717
EPS, basic−$0.21−$17.09−$14.86$17.41−$10.89−$11.66−$12.92−$13.47−$16.92−$16.68−$15.94$4.22
EPS, diluted−$0.21−$17.09−$14.86$17.35−$10.89−$11.66−$12.92−$13.60−$16.92−$16.68−$15.94−$6.12
Weighted average shares, basic19333333333333
Weighted average shares, diluted19333333333334
EBITDA−36−44−3858−28−32−34−35−45−44−44−71
Depreciation & amortization111111000000
EBIT−37−45−3957−29−33−34−36−45−45−44−71